Bone Marrow Transplantation

Top Story

Trial of KD025 for chronic GVHD meets primary endpoint at interim analysis

November 12, 2019

ASH elects three to leadership positions

October 31, 2019
ASH announced the election of three clinicians to leadership positions within the society. Jane Winter, MD, will serve a 1-year term as vice president, followed…

Hematologists, oncologists elected to National Academy of Medicine

October 30, 2019
The National Academy of Medicine announced the election of 90 regular members and 10 international members. Election to the academy — considered one of the highest…

NCI-sponsored clinical trials cost-effective, ‘practice influential’

October 22, 2019
A study by the NCI-sponsored SWOG Cancer Research Network showed nearly half of the network’s phase 3 clinical trials influenced clinical care guidelines or new…
More Headlines »

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »